Cost-effectiveness of Infloran (TM) in Treating Acute Childhood Diarrhea in Phramongkutklao Hospital
Not Applicable
- Conditions
- Acute Diarrhea
- Interventions
- Drug: Probiotic - Infloran
- Registration Number
- NCT01273012
- Lead Sponsor
- Phramongkutklao College of Medicine and Hospital
- Brief Summary
The purpose of this study is to determine whether the probiotic Infloran is cost-effective in treating acute childhood diarrhea.
- Detailed Description
Probiotics have been proved to shorten duration of diarrhea in children; whether they are cost-effective is less clear. We'd like to validate the use of Infloran, a proprietary probiotic sold in Thailand, in terms of its cost-effectiveness compared to standard diarrhea care in our hospital setting.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
- Children 3 months to 6 years of age
- Hospitalized due to acute diarrhea
Exclusion Criteria
- History of probiotic treatment in this episode of illness
- History of use of other anti-diarrheal medications
- Chronic gastrointestinal disease(s)
- Severe dehydration
- Severe systemic disease(s)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Probiotic - Infloran The group of patients treated with placebo. Infloran Probiotic - Infloran The group of patients treated with Infloran.
- Primary Outcome Measures
Name Time Method monetary cost of hospitalization in Thai Baht from admission to discharge date, approximately 1-7 days
- Secondary Outcome Measures
Name Time Method days of hospitalization from admission to discharge date, approximately 1-7 days
Trial Locations
- Locations (1)
Department of Pediatrics, Phramongkutklao Hospital
🇹ðŸ‡Bangkok, Thailand